Global disproportionality analysis of anxiolytic medication-associated cardiovascular and motor impairment disorders, 1967–2024: An international pharmacovigilance database
Journal of Affective Disorders · 2026
DOI: 10.1016/j.jad.2025.120629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Jaehyeong Cho und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea; Department of Medicine, …. Hauptthemen laut MEDLINE: Pharmacovigilance, Anti-Anxiety Agents, Cardiovascular Diseases, Anxiety Disorders. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Ministry of Health and Welfare, Ministry of Food and Drug Safety, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
BACKGROUND: Anxiolytics, commonly prescribed for anxiety disorders, have been reported with various adverse events, but comprehensive research on their cardiovascular and motor side effects is limited. METHODS: This study utilized a global pharmacovigilance database, covering 1967 to 2024. We analyzed the incidence of cardiovascular and motor impairment disorders (bradyarrhythmia, coordination abnormality, dysarthria, dyskinesia, and hypotension) reported with anxiolytic use, stratified by sex and age. The information component (IC) with IC025 and reporting odds ratio (ROR) with 95 % CI were calculated using a Bayesian report-non-report analysis. RESULTS: Among 887,564 reports of all-cause adverse events in database, 42,301 cases (male, n = 3486 [31.73 %]) were identified as anxiolytic-related. All cardiovascular and motor impairment disorders analyzed showed significant signal detection with anxiolytics, with coordination abnormalities showing the highest ROR (4.69 [95 % CI, 4.50-4.85]; IC, 2.13 [IC025, 2.06]). Benzodiazepines were significantly reported with all five events, as dysarthria showing the highest ROR (8.40 [8.09-8.72]; 3.01 [2.95]). Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) were also detected with anxiolytic-related dysfunctions, except for hypotension. The highest ROR for SNRIs was found in coordination abnormalities (3.58 [3.30-3.88]; 1.81 [1.68]) and for SSRIs in bradyarrhythmia (4.41 [4.29-4.54]; 2.10 [2.06]). CONCLUSION: Although our findings did not allow for causal inference, anxiolytics are effective in managing anxiety disorder symptoms, but safety concerns persist, especially related to cardiovascular and motor dysfunctions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea; Department of Medicine, CHA University School of Medicine, Seongnam, South Korea.
- Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea; Department of Regulatory Science, Kyung Hee University, Seoul, South Korea.
- Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea; Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea.
- Department of Pharmacy Practice and Clinical Research, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.
- Research Centre on Health Services and Quality of Life, Assistance Publique-Hôpitaux de Marseille, Aix Marseille University, Marseille, France.
- Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, South Korea; International Health Care Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seo…
Förderung
- Ministry of Health and Welfare
- Ministry of Food and Drug Safety
- Ministry of Science and ICT, South Korea
Zitieren
APA
Cho, J., Lee, K., Woo, S., Park, J., Jo, H., Oh, J., Kim, T. H., Wen, X., Fond, G., Boyer, L., Wang, S. M., Choi, S., & Yon, D. K. (2026). Global disproportionality analysis of anxiolytic medication-associated cardiovascular and motor impairment disorders, 1967–2024: An international pharmacovigilance database. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.120629
Vancouver
Cho J, Lee K, Woo S, Park J, Jo H, Oh J, et al. Global disproportionality analysis of anxiolytic medication-associated cardiovascular and motor impairment disorders, 1967–2024: An international pharmacovigilance database. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2025.120629
BibTeX
@article{Cho2026,
author = {Cho, Jaehyeong and Lee, Kyeongmin and Woo, Selin and Park, Jaeyu and Jo, Hyesu and Oh, Jiyeon and Kim, Tae Hyeon and Wen, Xuerong and Fond, Guillaume and Boyer, Laurent and Wang, Sheng-Min and Choi, Suein and Yon, Dong Keon},
title = {Global disproportionality analysis of anxiolytic medication-associated cardiovascular and motor impairment disorders, 1967–2024: An international pharmacovigilance database},
journal = {Journal of Affective Disorders},
year = {2026},
doi = {10.1016/j.jad.2025.120629}
}
EUVIMED